Results 31 to 40 of about 151,084 (348)

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study [PDF]

open access: yes, 2015
Objective: To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA).
Bonin, Randi   +15 more
core   +1 more source

SPONDYLITIS. [PDF]

open access: yesJournal of the American Medical Association, 1892
n ...
openaire   +2 more sources

Comparison of Pyogenic Spondylitis and Tuberculous Spondylitis [PDF]

open access: yesAsian Spine Journal, 2014
Pyogenic spondylitis and tuberculous spondylitis are common causes of spinal infection. It is difficult to differentiate tuberculous spondylitis and pyogenic spondylitis clinically and radiologically. Recently magnetic resonance imaging has been reported to be beneficial for early diagnosis and differential diagnosis of the spondylitis, and is being ...
openaire   +4 more sources

Spontaneous Spondylodiscitis - Epidemiology, Clinical Features, Diagnosis and Treatment

open access: yesFolia Medica, 2017
Spontaneous spondylodiscitis is a rare but serious infectious disease which is a combination of an inflammatory process, involving one or more adjacent vertebral bodies (spondylitis), the intervertebral discs (discitis) and finally - the neighboring ...
Petkova Aneta S.   +2 more
doaj   +1 more source

Interleukin 17A inhibitor secukinumab in the treatment of patients with psoriatic arthritis

open access: yesKlinicist, 2022
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease associated with psoriasis and characterized by various presentation, course, and response to treatment.
N. A. Shostak   +4 more
doaj   +1 more source

Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia : Results From a UK National Register [PDF]

open access: yes, 2017
The British Society for Rheumatology (BSR) Biologics Register in Ankylosing Spondylitis is funded by the BSR and they have receive funds for this from Pfizer, AbbVie and UCB.
Atzeni, Fabiola   +8 more
core   +2 more sources

Ankylosing Spondylitis: a trade Off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia [PDF]

open access: yes, 2019
The frequency of HLA-B27 in patients with Ankylosing Spondylitis (AS) is over 85%. There are more than 170 recognized HLA-B27 alleles but the majority of them is not sufficiently represented for genetic association studies.
Cauli, A   +5 more
core   +2 more sources

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

open access: yesAnnals of the Rheumatic Diseases, 2018
Objectives To evaluate the efficacy and safety of risankizumab, a humanised monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23), in patients with active ankylosing spondylitis (AS).
D. Baeten   +15 more
semanticscholar   +1 more source

Thoracolumbar tuberculosis spondylitis: an analytical literature review of surgical reconstruction techniques

open access: yesГений oртопедии, 2023
Introduction Tuberculous spondylitis is the most common extrapulmonary tuberculosis. The thoracolumbar lesion due to tuberculous spondylitis is one of the most difficult locations for surgical treatment. Analysis of the recent literature shows a limited
Andrey A. Karpushin   +3 more
doaj   +1 more source

Level of adherence to prescribed exercise in spondyloarthritis and factors affecting this adherence: a systematic review [PDF]

open access: yes, 2019
Adherence is a primary determinant of the effectiveness of any intervention. Exercise is considered essential in the management of spondyloarthritis (SpA); however, the overall adherence to exercise programmes and factors affecting adherence are unknown.
Coulter, EH   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy